Cannabinoids and Chronic Liver Diseases.

Int J Mol Sci · 2022 · PMC9408890 · PMID 36012687

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

This discrepancy may exist, in part, due to the proportion of patients with advanced liver fibrosis in clinical studies, where side effects or drug-induced liver injury may be significant issues.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.